Artelo Biosciences, Inc.

NasdaqCM:ARTL Stock Report

Market Cap: US$3.7m

Artelo Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ARTL?
Owner TypeNumber of SharesOwnership Percentage
Institutions25,7310.797%
Individual Insiders26,7260.828%
General Public3,175,24398.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.9%.


Top Shareholders

Top 11 shareholders own 1.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0.63%
Gregory Gorgas
20,446US$23.5k0%no data
0.61%
Geode Capital Management, LLC
19,808US$22.8k0%no data
0.18%
Tower Research Capital Europe Limited
5,823US$6.7k19.6%no data
0.12%
Connie Matsui
3,778US$4.3k0%no data
0.026%
Robert Emanuele
834US$959.10%no data
0.026%
Steven Kelly
834US$959.10%no data
0.026%
Douglas Blayney
834US$959.10%no data
0.0014%
Citigroup Inc.,Banking and Securities Investments
46US$53.10%no data
0.00081%
Bank of America Corporation, Asset Management Arm
26US$30.10%no data
0.00062%
Morgan Stanley, Investment Banking and Brokerage Investments
20US$23.00%no data
0.00025%
Rothschild Investment LLC
8US$9.30%no data